6-O-Methylguanine CAS 20535-83-5
Copia Cum puritate, Commercial Productio
Nomen chemicum: 6-O-Methylguanine
CAS: 20535-83-5
| Nomen chemicum | 6-O-Methylguanine |
| Synonyma | 2-Amino-6-Methoxypurine |
| CAS Number | 20535-83-5 |
| CATTUS Number | RF-PI509 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C6H7N5O |
| M. Pondus | 165.16 |
| Liquescens punctum | >300℃ (lit.) |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Off-White Crystalline pulveris |
| Asssay / Analysis Methodo | ≥98.5% (HPLC) |
| Damnum in Siccatio | ≤0.50% |
| Residere in Ignition | ≤0.50% |
| Totalis immunditias | ≤1.5% |
| Test Standard | Enterprise Standard |
| Consuetudinem | Medium Nelzarabine (CAS: 121032-29-9), T-ALL & T-LBL |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.
6-O-Methylguanine (CAS: 20535-83-5) adhiberi potest ut medium in synthesi Nelzarabini (CAS: 121032-29-9).Nelarabine est prodrug pro deoxyguanosino analogo-9-beta-D-arabinofuranosyl guanine (ara-G).Nelarabines demethylates in partes adenosinae deaminase (ADA) et in ara-G vertit.Nelarabine primum a GlaxoSmithKline feliciter elaboratum est.Die 28 Octobris 2005 approbante Administratione US Cibus et medicamentis, novum medicamentum factum est ad sanandum leukemia lymphoblastica acuta (T-ALL) et T-Cella lymphoblasticlymphoma (T-LBL) quae saltem renituntur. chemotherapy duo genera diaetam vel relapsus cum curatione initiali.Hoc novum medicamentum publice in Civitatibus Foederatis Americae MMVI recensetur.
